US equities |
MU $1,035.84 ▼-4.79% NVDA $230.48 ▼-2.94% SNDK $1,609.46 ▼-4.90% AMD $620.68 ▼-3.90% INTC $107.08 ▼-5.34% AAPL $340.42 ▲+1.11% META $720.89 ▼-0.06% SPCX $160.57 ▼-4.19%
FinancialContent

Latest News about Alexander Somjen

Recent news which mentions Alexander Somjen

Magic Mushrooms For Anorexia? Clinical Study Receives FDA Approval For Phase 2 Trial
Tickers ORIG
Tags ORIG Xpira Pharmaceuticals Alexander Somjen
From Benzinga
Origin Therapeutics Attaches Clairvoyant To Its Portfolio, Fueling Fast Market Strategy For Psilocybin Therapy
Tags Psychedelics Financing Damian Kettlewell
From Benzinga
New Psychedelic Investment Opportunity: Look For "ORIG" (Origin Therapeutics) On The CSE Starting June 6
Tickers CSE IPOS
Tags Markets Psychedelics Market News
From Benzinga